Methenamine Hippurate
**Methenamine hippurate** is a urinary tract antiseptic primarily utilized for the prophylaxis of recurrent urinary tract infections (UTIs). * **Clinical Utility:** It is not commonly used as a first-line agent in veterinary medicine, and robust evidence confirming its efficacy in dogs and cats is limited. It is generally reserved for highly resistant, recurrent lower UTIs where conventional antibiotic therapy has failed or is contraindicated. * **Mechanism Dependency:** Its efficacy is strictly dependent on an acidic urinary environment (pH < 6.5, ideally < 5.5). In alkaline urine, the drug remains inactive. * **Spectrum:** When activated, it provides broad-spectrum, non-specific bactericidal activity against both gram-positive (*Staphylococcus*, *Enterococcus*) and gram-negative (*E. coli*, *Pseudomonas*, *Proteus*) organisms, and reportedly some fungal pathogens. * **Clinical Pearl:** Because it converts to formaldehyde, bacteria do not develop plasmid-mediated or chromosomal resistance to it, making it uniquely valuable for chronic prophylaxis.
กลไกการออกฤทธิ์: Methenamine is a prodrug that requires an acidic environment for activation. * **Hydrolysis Pathway:** In an acidic urinary environment (pH < 6.5) → **methenamine** is hydrolyzed → **formaldehyde** + **ammonia**. * **Bactericidal Action:** **Formaldehyde** acts as a non-specific bactericidal agent by denaturing bacterial proteins and nucleic acids. * **Role of Hippurate:** The **hippuric acid** salt component serves a dual purpose: it acts as a weak acid to help lower the urinary pH (facilitating the conversion to formaldehyde) and possesses mild, non-specific antibacterial activity of its own. * **Systemic Inactivity:** At physiological blood pH (7.4), methenamine remains stable and inactive, ensuring that formaldehyde is only generated locally within the urinary bladder.
ขนาดยาตามชนิดสัตว์
- Urinary tract infection prophylaxis · 250 mg · PO · q12h · Methenamine hippurate
- Urinary tract infection prophylaxis · 10 mg/kg · PO · q6h · Methenamine mandelate; use with ammonium chloride to acidify urine and increase effectiveness
- Urinary tract infection prophylaxis · 10 mg/kg · PO · q6h · Methenamine mandelate
- Urinary tract infection prophylaxis · 10-20 mg/kg · PO · q8-12h · Methenamine mandelate; urine pH may need to be lowered by use of an acidifying diet and/or urinary acidifiers
ขนาดยาเป็นข้อมูลอ้างอิงทางคลินิกสำหรับสัตวแพทย์ผู้มีใบอนุญาต โปรดตรวจสอบกับฉลากล่าสุดและผู้ป่วยแต่ละรายเสมอ
วิธีการให้ยา
ข้อห้ามใช้
- Hypersensitivity to methenamine or its salts
- Renal insufficiency
- Metabolic acidosis
- Severe hepatic impairment (due to ammonia production during hydrolysis)
- Severe dehydration
อาการไม่พึงประสงค์
- Gastrointestinal irritation (nausea, vomiting, anorexia)
- Dysuria (secondary to formaldehyde irritation with long-term use)
- Systemic acidosis (potential)
- Lipoid pneumonitis (reported in humans using oral suspension)
อันตรกิริยาระหว่างยา
- Sulfamethiazole · Not recommended; an insoluble precipitate may form in the urine.
- Urine Alkalinizing Drugs (e.g., calcium/magnesium antacids, carbonic anhydrase inhibitors, citrates, sodium bicarbonate, thiazide diuretics) · May reduce the efficacy of methenamine by preventing its conversion to formaldehyde in the urine.
การติดตาม
- Urine pH (must remain < 6.5)
- Clinical efficacy (resolution or prevention of UTI symptoms)
- Urinalysis and urine cultures
การได้รับยาเกินขนาด
Dogs have tolerated single IV dosages of up to 600 mg/kg of methenamine hippurate without overt toxic effects. **Management of Large Oral Overdoses:** * Implement established gut emptying protocols (emesis/gastric lavage) if ingestion is recent. * Maintain hydration status with intravenous fluids. * Provide symptomatic and supportive care as required, monitoring for systemic acidosis and gastrointestinal distress.
ข้อมูลอ้างอิงยาของ VetSheet มีไว้สำหรับสัตวแพทย์ผู้มีใบอนุญาตเพื่อช่วยในการตัดสินใจทางคลินิก ไม่ใช่สิ่งทดแทนการวินิจฉัยของผู้เชี่ยวชาญหรือฉลากล่าสุดของผู้ผลิต